Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Drugs for PCOS can affect metabolism, so understanding their effects is important for managing health risks.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Ovarian hyperthecosis can cause symptoms even with normal testosterone levels, and surgery can improve these symptoms.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Surgery removed an ovarian tumor, improving her symptoms and normalizing testosterone levels.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

The questionnaire is valid and reliable but needs more testing for future predictions.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Ashwagandha root improved symptoms of nonclassic 11-hydroxylase deficiency in an elderly woman.

Most women with PCOS have insulin resistance, especially those with phenotype B.

People with polycystic ovary syndrome often have low levels of vitamin D.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.